CARERATINGBSECARE Ratings LtdMediumNeutral
Announced Wed, 13 May · 21:18 IST

Press Release and Investor Presentation

Mgmt Guided Margin ImprovementInvestor Communications View source PDF

CARERATING · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+13.0%1-day move
₹1595.00
prior close
₹1700.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.9+2.2+0.8+1.3+13.0+8.4+10.7+8.0+7.6+6.6+0.6+3.4+3.9
Up moveDown movePending
AI summary

CARE Ratings reported record standalone and consolidated profit for FY26, with standalone PAT growing 18% YoY to Rs. 174.39 Cr and consolidated PAT growing 24% to Rs. 173.69 Cr. Standalone revenue from operations increased 15% to Rs. 387.72 Cr, while consolidated revenue rose 18% to Rs. 473.07 Cr, supported by diversification with non-ratings and overseas businesses now contributing 11% to consolidated revenue. EBITDA margins expanded significantly — standalone EBITDA margin improved to 48% (up from prior year) with 21% YoY growth, reflecting strong operating leverage and improved productivity. The board recommended a final dividend of Rs. 14 per share, bringing total FY26 dividend to Rs. 22 per share. CARE Ratings launched PaRRVA (Past Risk and Return Verification Agency) in collaboration with SEBI and NSE, and continued integrating AI and advanced analytics across operations.

Likely market impact

Strong financial performance with margin expansion signals operational efficiency gains and franchise strength, which is positive for shareholders. Growing contribution from non-ratings and overseas subsidiaries reduces dependency on core ratings and supports multi-segment growth.